Bai, O., Chlan-Fourney, J., Bowen, R., et al (2003) Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research, 71, 127–131.
Briffa, D. & Meehan, T. (1998) Weight changes during clozapine treatment. Australian and New Zealand Journal of Psychiatry, 32, 718–721.
Broadbelt, K., Byne, W. & Jones, L. B. (2002) Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medical prefrontal cortex. Schizophrenia Research, 58, 75–81.
Brown, S., Birtwistle, L. R. & Thompson, C. (1999) The unhealthy lifestyle of people with schizophrenia. Psychological Medicine, 29, 697–701.
Brown, S., Barraclough, B. & Inskip, H. (2000) Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212–217.
Chong, S. A., Tan, E. C., Tan, C. H., et al (2003) Smoking and tardive dyskinesia: lack of involvement of the CYPIA2 gene. Journal of Psychiatry and Neuroscience, 28, 185–189.
Christensen, O. & Christensen, E. (1988) Fat consumption and schizophrenia. Acta Psychiatrica Scandinavica, 78, 587–591.
Colagiuri, S. & Miller, J. B. (2002) The ‘carnivore connection’ – evolutionary aspects of insulin resistance. European Journal of Clinical Nutrition, 56 (suppl. 1), S30–S35.
Cotman, C. W. & Berchtold, N. C. (2002) Exercise: a behavioural intervention to enhance brain health and plasticity. Trends in Neuroscience, 25, 295–301.
Duan, W., Guo, Z., Jiang, H., et al (2003) Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology, 144, 2446–2453.
Glenny, A. M., O'Meara, S., Melville, A., et al (1997) The treatment and prevention of obesity: a systematic review of the literature. International Journal of Obesity, 21, 715–737.
Gorski, J. A., Zeiler, S. R., Tamowski, S., et al (2003) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. Journal of Neuroscience, 23, 6856–6865.
Gothelf, D., Falk, B., Singer, P., et al (2002) Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. American Journal of Psychiatry, 159, 1055–1057.
Hagg, S., Soderberg, S., Ahren, B., et al (2001) Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. Journal of Clinical Psychiatry, 62, 843–848.
Henderson, L., Gregory, J. & Simon, G. (2002) The National Diet and Nutrition Survey: Adults Aged 19–65. London: Stationery Office.
Homel, P., Casey, D., Allison, D. B. (2002) Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophrenia Research, 55, 277–284.
Hong, C.-J., Younger, W.-Y., Lin, C.-H., et al (2003) Association study of a brain-derived neurotrophic factor Val 66 Met polymorphism and clozapine response of schizophrenic patients. Neuroscience Letters, 349, 206–208.
Hopper, K. & Wanderling, J. (2000) Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISOS, the WHO collaborative follow-up project. Schizophrenia Bulletin, 26, 835–846.
Jablensky, A., Sartorius, N., Ernberg, G., et al (1992) Schizophrenia: Manifestations, Incidence and Course in Different Cultures. A World Health Organization Ten-country Study. Psychological Medicine Monograph Supplement 20. New York: Cambridge.
Jakes, R. W., Day, N. E., Khaw, K. T., et al (2003) Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. European Journal of Clinical Nutrition, 57, 1089–1096.
Kaur, G. & Kulkarni, S. K. (2003) Studies of modulation of feeding behaviour by atypical antipsychotics in female mice. Progress in Neuropsychopharmacology and Biological Psychiatry, 26, 277–285.
Kelly, C. & McCreadie, R. G. (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry, 156, 1751–1757.
Lessman, V., Gottmann, K. & Malcangio, M. (2003) Neurotrophin secretion: current facts and future prospects. Progress in Neurobiology, 69, 341–379.
Levin, E. D. & Rezvani, A. H. (2002) Nicotinic treatment for cognitive dysfunction. Current Drug Targets in CNS and Neurological Disorders, 1, 423–431.
Mann, J. I. (2002) Diet and risk of coronary heart disease and type 2 diabetes. Lancet, 360, 783–789.
McCreadie, R., Macdonald, E., Blacklock, C., et al (1998) Dietary intake of schizophrenic patients in Nithsdale, Scotland: a case-control study. BMJ, 317, 784–785.
Meiers, R. L. (1973) Relative hypoglycaemia in schizophrenia. In Orthomolecular Psychiatry (eds Hawkings, D. & Pauling, L.), pp. 452–462. San Francisco, CA: WH Freeman.
Mellor, J. E., Laugharne, J. D. E. & Peet, M. (1996) Omega-3 fatty acid supplementation in schizophrenic patients. Human Psychopharmacology, 11, 39–46.
Molteni, R., Barnard, R. J., Ying, Z., et al (2002) A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience, 112, 803–814.
Mukherjee, S., Schnur, D. B. & Reddy, R. (1989) Family history of type 2 diabetes in schizophrenic patients. Lancet, i, 495.
Nakagawa, T., Tsuchida, A., Itakura, Y., et al (2000) Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes, 49, 456–444.
O'Dea, K. (1991) Westernisation, insulin resistance and diabetes in Australian aborigines. Medical Journal of Australia, 155, 258–264.
Parker, L., Lamont, N., Unwin, N., et al (2003) A life course study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49–51 years. Diabetic Medicine, 20, 406–415.
Patkar, A. A., Gopalakrishnan, R., Lundy, A., et al (2002) Relationships between tobacco smoking and positive and negative symptoms in schizophrenia. Journal of Nervous and Mental Disease, 190, 604–610.
Peet, M. (2002) Essential fatty acids: theoretical aspects and treatment implications for schizophrenia and depression. Advances in Psychiatric Treatment, 8, 223–229.
Peet, M. (2004) International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. British Journal of Psychiatry in press.
Rimm, E. B., Chan, J., Stampfer, M. J., et al (1995) Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ, 310, 555–559.
Ryan, M. C. M., Collins, P. & Thakore, J. H. (2003) Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia. American Journal of Psychiatry, 160, 284–289.
Sernyak, M. J., Leslie, D. L.
Alarcon, R. D., et al (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry, 159, 561–566.
Silverstone, T., Smith, G. & Goodall, E. (1988) Prevalence of obesity in patients receiving depot antipsychotics. British Journal of Psychiatry, 153, 214–217.
Sowell, M. O., Mukhopadhyay, N., Cavazzoni, P., et al (2002) Hyperglycaemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone or placebo. Journal of Endocrinology and Metabolism, 87, 2918–2923.
Stokes, C. (2003) Dietary Sugar Intake and the Severity of Symptoms of Schizophrenia. MSc Thesis. Sheffield: University of Sheffield.
Szekeres, G., Juhasz, A., Rimanocay, A., et al (2003) The C270T polymorphism of the brain-derived neurotrophic factor is associated with schizophrenia. Schizophrenia Research, 65, 15–18.
Tucker, K. L. & Buranapin, S. (2001) Nutrition and ageing in developing countries. Journal of Nutrition, 131, 2417S–2423S.
Ukkola, O. & Bouchard, C. (2001) Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. Annals of Medicine, 33, 79–80.
Webster, M. J., Weikert, C. S., Herman, M. M., et al (2002) BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Research. Developmental Brain Research, 139, 139–150.
Weickert, C. S., Hyde, T. M., Lipska, B. K., et al (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Molecular Psychiatry, 8, 592–610.
Werneke, U., Taylor, D., Sanders, T. A. B., et al (2003) Behavioural management of antipsychotic-induced weight gain: a review. Acta Psychiatrica Scandinavica, 108, 252–259.
World Health Organization (1979) Schizophrenia: An International Follow-up Study
New Yok: John Wiley.
World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseasses. WHO Technical Report Series 916. Geneva: WHO.
Zabeau, L., Lavens, D., Peelman, F., et al (2003) The ins and outs of leptin receptor activation. FEBS Letters, 546, 45–50.